Patents by Inventor Ching-Chu Wu

Ching-Chu Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF LACTIC ACID BACTERIUM SET FOR PREVENTING OR TREATING NSAID-INDUCED GASTRIC ULCER
    Publication number: 20240165170
    Abstract: The present invention provides a method for preventing and/or treating a NSAID-induced gastric ulcer. The method comprises administrating an effective amount of a lactic acid bacterium set to a subject. The lactic acid bacterium set comprises Lactobacillus plantarum GKD7 and Pediococcus acidilactici GKA4.
    Type: Application
    Filed: March 6, 2023
    Publication date: May 23, 2024
    Applicant: GRAPE KING BIO LTD.
    Inventors: Chin-Chu CHEN, Yen-Lien CHEN, Shin-Wei LIN, You-Shan TSAI, Ci-Sian WANG, Yu-Hsin HOU, Yang-Tzu SHIH, Ching-Wen LIN, Ya-Jyun CHEN, Jia-Lin JIANG, Zi-He WU, Yen-Po CHEN, Tzu Chun LIN
  • COMPLEX PROBIOTIC COMPOSITION AND METHOD FOR IMPROVING EXERCISE PERFORMANCE OF SUBJECT WITH LOW INTRINSIC AEROBIC EXERCISE CAPACITY
    Publication number: 20240139262
    Abstract: The present disclosure relates to a complex probiotic composition and a method for improving exercise performance of a subject with low intrinsic aerobic exercise capacity. The complex probiotic composition, which includes Lactobacillus rhamnosus GKLC1, Bifidobacterium lactis GKK24 and Clostridium butyricum GKB7, administered to the subject with the low intrinsic aerobic exercise capacity in a continuation period, can effectively reduce serum lactic acid and serum urea nitrogen after aerobic exercise, reduce proportion of offal fat and/or increase liver and muscle glycogen contents, thereby being as an effective ingredient for preparation of various compositions.
    Type: Application
    Filed: October 13, 2023
    Publication date: May 2, 2024
    Inventors: Chin-Chu CHEN, Yen-Lien CHEN, Shih-Wei LIN, Yen-Po CHEN, Ci-Sian WANG, Yu-Hsin HOU, Yang-Tzu SHIH, Ching-Wen LIN, Ya-Jyun CHEN, Jia-Lin JIANG, You-Shan TSAI, Zi-He WU
  • Hemoglobin A1c-specific aptamer, hemoglobin-specific aptamer, and applications thereof
    Patent number: 9086406
    Abstract: The present invention provides a Hemoglobin A1c-specific aptamer and a Hemoglobin-specific aptamer. The aptamers were selected in vitro using SELEX and a microfluidic chip system. The aptamers established low free energy, thus were more stable than conventional antibodies. The high specificity of the aptamers to Hemoglobin A1c or Hemoglobin allows them to be effectively used in diagnosis of diabetes and/or anemia.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: July 21, 2015
    Assignee: NATIONAL TSING HUA UNIVERSITY
    Inventors: Gwo-Bin Lee, Shu-Chu Shiesh, Ching-Chu Wu, Hsin-I Lin, Ko-Wei Chang
  • HEMOGLOBIN A1c-SPECIFIC APTAMER, HEMOGLOBIN-SPECIFIC APTAMER, AND APPLICATIONS THEREOF
    Publication number: 20150111306
    Abstract: The present invention provides a Hemoglobin A1c-specific aptamer and a Hemoglobin-specific aptamer. The aptamers were selected in vitro using SELEX and a microfluidic chip system. The aptamers established low free energy, thus were more stable than conventional antibodies. The high specificity of the aptamers to Hemoglobin A1c or Hemoglobin allows them to be effectively used in diagnosis of diabetes and/or anemia.
    Type: Application
    Filed: March 25, 2014
    Publication date: April 23, 2015
    Applicant: National Tsing Hua University
    Inventors: Gwo-Bin Lee, Shu-Chu Shiesh, Ching-Chu Wu, Hsin-I Lin, Ko-Wei Chang